QLG1074

· Qilu Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QLG1074, covering 2024-05-09 to 2024-05-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of QLG1074 Combined With Background Therapy in Subjects With Active Lupus Nephritis [Phase 3]